Protagonist Therapeutics Inc (PTGX)
Current ratio
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 627,553 | 355,577 | 324,881 | 316,941 | 235,736 | 243,077 | 276,617 | 304,302 | 341,522 | 340,736 | 327,687 | 371,818 | 285,508 | 315,606 | 204,151 | 217,466 | 125,986 | 145,311 | 144,023 | 137,320 |
Total current liabilities | US$ in thousands | 39,910 | 21,274 | 27,867 | 26,398 | 23,229 | 31,179 | 36,754 | 40,088 | 43,456 | 44,016 | 39,156 | 42,973 | 34,515 | 40,241 | 38,563 | 35,360 | 36,372 | 35,406 | 30,776 | 33,323 |
Current ratio | 15.72 | 16.71 | 11.66 | 12.01 | 10.15 | 7.80 | 7.53 | 7.59 | 7.86 | 7.74 | 8.37 | 8.65 | 8.27 | 7.84 | 5.29 | 6.15 | 3.46 | 4.10 | 4.68 | 4.12 |
March 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $627,553K ÷ $39,910K
= 15.72
The current ratio of Protagonist Therapeutics Inc has shown a generally positive trend over the past few quarters, indicating the company's ability to meet its short-term obligations with its current assets. The ratio has consistently remained above 1, indicating that the company has more than enough current assets to cover its current liabilities.
There has been a notable increase in the current ratio from the end of 2019 to the latest quarter of 2024, with the ratio peaking at 16.71 in December 2023. This suggests that the company has significantly strengthened its liquidity position over this period. However, it's important to note that the ratio has fluctuated somewhat, reaching its lowest point of 3.46 in March 2020, although it has since recovered and remained relatively stable.
Overall, the current ratio of Protagonist Therapeutics Inc demonstrates sound liquidity management and a healthy balance between current assets and liabilities, indicating a strong financial position to support its operations and growth.
Peer comparison
Mar 31, 2024